We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+15.64%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$107M
AUM Growth
+$505K
Cap. Flow
-$4.95M
Cap. Flow %
-4.64%
Top 10 Hldgs %
45.12%
Holding
91
New
3
Increased
11
Reduced
50
Closed
7

Top Buys

Rank Stock Value
1
BKSY icon
BlackSky Technology
BKSY
+$1.86M
2
MDXH icon
MDxHealth
MDXH
+$840K
3
BDSX icon
Biodesix
BDSX
+$533K
4
ELUT icon
Elutia
ELUT
+$298K
5
ORN icon
Orion Group Holdings
ORN
+$231K

Sector Composition

Rank Sector Weight
1 Healthcare 60.78%
2 Technology 24.51%
3 Communication Services 5.19%
4 Consumer Staples 3.8%
5 Industrials 2.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.02T
$11M 10.28%
12,376
-246
-2% -$221K
NTRA icon
2
Natera
NTRA
$47.3B
$6.9M 6.47%
54,350
-3,200
-6% -$367K
MSFT icon
3
Microsoft
MSFT
$3.71T
$5.6M 5.25%
13,010
-1,566
-11% -$669K
IDXX icon
4
Idexx Laboratories
IDXX
$42.2B
$4.9M 4.6%
9,700
-800
-8% -$389K
AXGN icon
5
Axogen
AXGN
$2.6B
$3.97M 3.73%
283,399
-5,950
-2% -$65.8K
AMD icon
6
Advanced Micro Devices
AMD
$780B
$3.51M 3.29%
21,404
-1,150
-5% -$175K
ELUT icon
7
Elutia
ELUT
$36.4M
$3.26M 3.06%
856,552
+76,450
+10% +$298K
VCYT icon
8
Veracyte
VCYT
$3.42B
$3.2M 3%
93,930
-4,900
-5% -$138K
LMAT icon
9
LeMaitre Vascular
LMAT
$1.84B
$3.14M 2.94%
33,786
-415
-1% -$36K
NEO icon
10
NeoGenomics
NEO
$2.23B
$2.67M 2.5%
180,800
-6,500
-3% -$102K
ABT icon
11
Abbott
ABT
$187B
$2.6M 2.44%
22,830
-2,050
-8% -$225K
MGNI icon
12
Magnite
MGNI
$3.46B
$2.06M 1.94%
149,075
OOMA icon
13
Ooma
OOMA
$637M
$1.91M 1.8%
168,100
+13,300
+9% +$131K
CTLP
14
DELISTED
Cantaloupe
CTLP
$1.81M 1.7%
244,600
AIRG icon
15
Airgain
AIRG
$68.8M
$1.76M 1.65%
233,000
-132,150
-36% -$941K
DGII icon
16
Digi International
DGII
$2.63B
$1.74M 1.63%
63,308
-6,900
-10% -$182K
INUV icon
17
Inuvo
INUV
$10.7M
$1.68M 1.58%
682,786
-7,579
-1% -$21.2K
MDXH icon
18
MDxHealth
MDXH
$71.4M
$1.55M 1.46%
747,375
+309,500
+71% +$840K
QUIK icon
19
QuickLogic
QUIK
$197M
$1.54M 1.45%
201,106
PFIE
20
DELISTED
Profire Energy, Inc
PFIE
$1.51M 1.41%
897,420
-10,000
-1% -$16K
XGN icon
21
Exagen
XGN
$184M
$1.42M 1.33%
458,871
-34,450
-7% -$89.3K
RMTI icon
22
Rockwell Medical
RMTI
$32.2M
$1.39M 1.3%
35,038
-3
-0% -$81
PSNL icon
23
Personalis
PSNL
$1.84B
$1.38M 1.3%
257,307
GIS icon
24
General Mills
GIS
$20.5B
$1.35M 1.27%
18,325
-2,000
-10% -$139K
USIO icon
25
Usio Inc
USIO
$78.4M
$1.34M 1.25%
982,193
-40,000
-4% -$60K

Similar funds

Perkins Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Perkins Capital Management held 91 positions worth $107M, up 0.48% from $106M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Perkins Capital Management withdrew a net $4.95M in Q3 2024, closing 7 positions and reducing 50 holdings. Its most notable exit was Augmedix, Inc. Common Stock, an estimated $1.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 58% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Perkins Capital Management opened a new position in BlackSky Technology worth $1.11M.

  • Perkins Capital Management's largest Q3 2024 buy was BlackSky Technology: 235,000 shares worth $1.11M.
  • Perkins Capital Management added most to MDxHealth in Q3 2024, an estimated $840K increase.
  • Perkins Capital Management's biggest Q3 2024 reduction was Airgain, cutting an estimated $941K.
  • Perkins Capital Management fully exited Augmedix, Inc. Common Stock in Q3 2024, selling an estimated $1.25M.
  • Perkins Capital Management's ten largest holdings make up 45% of its $107M portfolio in Q3 2024.
  • Perkins Capital Management opened 3 new positions and closed 7 in Q3 2024.
  • Perkins Capital Management's portfolio value rose 0.48% quarter-over-quarter to $107M.

Based on Perkins Capital Management's 13F filing for Q3 2024, filed 31 Oct 2024.